Building on Sipuleucel-T for Immunologic Treatment of Castration-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

Building on Sipuleucel-T for Immunologic Treatment of Castration-Resistant Prostate Cancer

Published:2013-01 Issue:1 Volume:20 Page:7-16
ISSN:1073-2748
Container-title:Cancer Control
language:en
Short-container-title:Cancer Control

Author:

Shore Neal D.¹,Mantz Constantine A.²,Dosoretz Daniel E.²,Fernandez Eduardo²,Myslicki Francisco A.³,Mccoy Candice⁴,Finkelstein Steven Eric³,Fishman Mayer N.⁵

Affiliation:

1. Carolina Urologic Research Center/Atlantic Urology Clinics, Myrtle Beach, South Carolina

2. 21st Century Oncology Translational Research Consortium, Fort Myers/Cape Coral, Plantation, Florida

3. 21st Century Oncology Translational Research Consortium, Fort Myers/Cape Coral, Scottsdale, Arizona

4. 21st Century Oncology Translational Research Consortium, Fort Myers/Cape Coral, Dendreon Corporation, Seattle, Washington

5. H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

Publisher

SAGE Publications

Subject

Oncology,Hematology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/107327481302000103

Reference66 articles.

1. Cancer statistics, 2012

2. Abiraterone and Increased Survival in Metastatic Prostate Cancer

3. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

4. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing of bioactive natural products in prostate cancer research and care: Promising discoveries and future directions;Intelligent Pharmacy;2024-07

2. Combination Treatment Options for Castration-Resistant Prostate Cancer;Prostate Cancer;2021-05-28

3. Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer;Clinical Cancer Research;2021-01-15

4. Membrane-encapsulated camouflaged nanomedicines in drug delivery;Nanomedicine;2019-08

5. Permanent 125 I prostate brachytherapy for castration‐resistant prostate cancer;International Journal of Urology;2018-12-04